Position in GILD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$12,254
-$1,264 QoQ
Shares Held
97
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,173
of 2,266 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Elevated Capital Advisors, LLC holds $4,373,518 across 13 Drug Manufacturers - General names. GILD ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,263 | $1,082,674 | |
| 2 | ABBV |
AbbVie Inc.
|
3,945 | $992,719 | |
| 3 | AMGN |
Amgen Inc
|
1,865 | $675,353 | |
| 4 | PFE |
Pfizer Inc
|
21,185 | $510,134 | |
| 5 | LLY |
ELI LILLY & Co
|
382 | $458,182 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,669 | $326,647 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,351 | $302,103 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
97 | $12,254 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,254 | 97 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $13,518 | 97 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $11,905 | 97 | Shares | Sole | 2026-01-27 | |
| 2022-03-31 | $588,911 | 9,906 | Shares | Sole | 2022-04-20 | |
| 2021-09-30 | $665,391 | 9,526 | Shares | Sole | 2021-10-07 | |
| 2021-03-31 | $492,415 | 7,619 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $349,152 | 5,993 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $263,755 | 4,174 | Shares | Sole | 2020-11-27 | |
| 2020-06-30 | $254,902 | 3,313 | Shares | Sole | 2020-09-11 | |
| No filing history on record for this holder in this stock. | ||||||